1050201-05-2Relevant academic research and scientific papers
Inhibition of PDGFR tyrosine kinase activity by a series of novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides - A SAR study on the bioisosterism of pyrimidine and imidazole
Mahboobi, Siavosh,Sellmer, Andreas,Eswayah, Asma,Elz, Sigurd,Uecker, Andrea,Boehmer, Frank-D.
, p. 1444 - 1453 (2008/09/21)
A series of N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides were synthesized and tested for inhibition of PDGFR and FLT3 autophosphorylation. The novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides, obtained by replacement of the pyrimidine system in Imatinib (1) with an imidazole ring, exhibit potent inhibitory activity on PDGFR, similar to the parent compound (IC50 (9e) = 0.2 μM; IC50 Imatinib (1) = 0.3 μM). Selectivity hereby seems to be conserved, as shown by the lack of activity on FLT3, a closely related class III receptor tyrosine kinase, which is not affected by the parent compound Imatinib.
